Research, development and innovations

Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less. – Marie Curie

The disciplines of medicine, nutritional science, pharmacy, chemistry and pharmaceutical technology are working closely together here at Wörwag Pharma. Like our company founder Dr. Fritz Wörwag, who developed the active ingredient benfotiamine into a milestone in the treatment of diabetic comorbidities, we are convinced that innovations are the key to enabling everyone to live a healthier life.

Collaboration within R&D and Innovation

External research and how we support it

Events you can meet us at

Find out where

Fritz Wörwag Research Prize

Learn more

Today our R&D activities have expanded into diabetes and associated diseases, nervous system, ageing of the locomotor system and strengthening of the immune system focusing on:

Improvement of biopharmaceutical characteristics of existing active substances, mainly biofactors like vitamins, minerals, trace elements but also new substances with confirmed biological activities
Introduction of new active substances or combinations of those
Development of new technological solutions or new dosage forms which can improve efficacy, safety or patients/customers adherence
Clinical development/studies related on new indications for new or existing APIs or combinations of APIs

Currently we have six products in the pipeline in different development phases. The evaluation of potential new candidates from internal and external sources is a continuous process of our team.

Collaboration within R&D and Innovation

Alone we can do so little; together we can do so much. – Helen Keller

For Wörwag Pharma, collaboration and cooperation in Research and Development are essential to innovate within our therapeutic areas and ultimately pave the way for new drugs and therapies. We are therefore actively reaching out to work with the academic community and commercial partners to establish long-term collaborations and an ever-growing network based on flexible cooperation models. Our memberships support us in this endeavor.

If we haven't talked yet and you think we should, feel free to contact us with your ideas, projects or services – or meet us here:

Upcoming events

Your contact

Dr. Timo Strohäker

Scouting and Innovation Manager

timo.strohaeker@woerwagpharma.com

External research and how we support it

The science of today is the technology of tomorrow. – Edward Teller

External research helps to expand the understanding of our products and the therapeutic areas we are working in. We therefore support independent external research in line with our commitment to scientific innovation and areas of unmet needs.

Wörwag Pharma provides financial and material support for Investigator Initiated Trials (IIT), Investigator Initiated Non-Interventional Studies (II-NIS) or preclinical research. To apply for our support, please fill in the appropriate form and send it to us via e-mail to claudia.reule@woerwagpharma.com:

We do not provide support for CME or non-CME educational activities, event sponsorships, or charitable contributions in this program.

What you should know if you want to apply for support for your research

What are biofactors?

Biofactors are substances required by the body for its normal, physiologic functioning and/or with health-beneficial and/or disease-preventive biological activities. Dietary biofactors include vitamins and pro-vitamins, minerals, enzymes, peptides, amino acids, fatty acids, phytochemicals and more.
_{(Frank et al. The role of biofactors in the prevention and treatment of age-related diseases. Biofactors. 2021;47(4):522-550.)}

What are the requirements?

• The scientific question addresses the areas of interest of Wörwag Pharma. • The scientific question being addressed complements the current scientific knowledge and not simply repeats existing studies. • The study corresponds to the current scientific standard in terms of study design and methodology and will be conducted in accordance with all applicable legal and regulatory principles, regulations and guidelines. • Independently from the country or region, the declaration of Helsinki in its current version applies, as well as ICH-GCP/Good Pharmacoepidemiology Practices. • Conclusion of a Study agreement, presence of favorable opinion of ethics and approval of national authorities, if applicable. • A commitment by the investigator/sponsor to publish the findings in an appropriate, transparent, and timely manner.

What are the areas of interest?

• Diabetes and associated diseases

• Nervous system

• Ageing of the locomotor system

• Strengthening of the immune system

How can I submit my application?

To submit your application, please complete the relevant form: request for support of clinical studies or request for support of preclinical studies.

Applications for the Dr. Fritz-Wörwag Research Prize 2024/25

In order to support research and science, we are announcing the 11^thDr. Fritz-Wörwag Research Prize 2024/25. The prize will be awarded for research work making a significant scientific contribution and containing new experimental or clinical findings in the field of

“Drug- and disease-associated biofactor deficiencies“

and is endowed with

€ 20,000.

Please read all relevant information about the application in this document carefully and send your submission to the Medical_GMA@woerwagpharma.com E-mail address.

Download the submission form

Winners of the Fritz Wörwag Research Prize

In 1988, our company founder Dr. Fritz Wörwag established the research prize named after him. Since then, an independent jury has decided on the awarding of the prize. The prize is awarded for work that makes a significant scientific contribution and contains new experimental or clinical findings on biofactors.

2021

Dr. Alexander Strom and Prof. Dr. med. Klaus Kisters

German Diabetes Centre, University of Düsseldorf and St. Anna-Hospital, Herne

2018

Prof. Dr. med. Dan Ziegler und Prof. Jacqueline A. Pettersen (2nd prize)

German Diabetes Centre, University of Düsseldorf and University of Northern British Columbia, Prince George

2013

Dr. med. Alin Stirban and Chune Liu (Junior Researcher Prize)

Profile Institute for Metabolic Research, Neuss and University of Freiburg Medical Center

2009

Prof. Dr. med. Vedat Schwenger

University of Heidelberg Medical Center

2007

Prof. Dr. Paul Thornalley und Dr. Nicole Schupp (Nachwuchspreis)

University of Warwick, U. K., and Pharmacology and Toxicology Institute, Würzburg

1999

Prof. Dr. med. Hans-Peter Hammes

Mannheim Medical Center

1996

Prof. Dr. med. Hilmar Stracke

Med. Clinic and Polyclinic of the University of Giessen

1994

Prof. Dr. Hans Konrad Biesalski and Prof. Dr. Walter Zidek

University of Hohenheim and Polyclinic of the University of Münster

1991

Prof. Dr. Roland Bitsch

Nutritional Sciences Institute of the University of Jena

1988

Prof. Dr. Klaus-Henning Krause

Friedrich Bauer Institute, Munich

Wörwag Pharma stands for a healthier life

We specialize in the prevention and treatment of diabetic comorbidities and secondary diseases and support you in maintaining or restoring your health.

1971

foundation in Germany

35+

sites worldwide

This is us